HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Supplement AER Compliance Costs Exceed FDA Estimates – Industry

This article was originally published in The Tan Sheet

Executive Summary

FDA’s estimate of supplement AER costs does not consider that firms must thoroughly investigate and evaluate all reports to determine whether they are serious and maintain records of reports, industry trade groups say.


Related Content

Supplement AER Under-Reporting Marks Tip Of Compliance Iceberg – FDA
FDA “Undercuts” NDI Guidance Opposition With Compliance Cost Estimate – CRN





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts